Services

Optimum Dosing Strategies’s ID – ODS open-architecture design allows integration and interoperability with a variety of third-party systems. ID – ODS is capable of exchanging information bi-directionally , giving health care practitioners vital access to the data they need at the point of care. Click here to contact us for further details about interfacing ID – ODS with your institutions electronic medical record.

 

Vancomycin Empiric Dosing

This page is part of the applications compiled for the […]

...

More

Vancomycin Bayesian Dosing

This page is part of the applications compiled for the […]

...

More

Meropenem MIC Distribution

This page is part of the applications compiled for the […]

...

More

Meropenem Single MIC

This page is part of the applications compiled for the […]

...

More

ID-ODS apps for the SHPA 2017 conference

Please find below a partial list of applications availa […]

...

More

ID-ODS: free Bayesian dose optimization application trusted by 1802 users…

ID-ODS: free Bayesian dose optimization application trusted by 1802 users…

Join the growing number of community of ID-ODS users worldwide! 1802 users signed up so far and counting! Last updated: 12/11/2019

More

See recent publication on ID – ODS!

See recent publication on ID – ODS!

A review article published in July, 2019 in the International Journal of Clinical Pharmacy indicates that ID-ODS is in a leading position versus its comparators for versatility, complexity and readiness for easy integration into clinical practice!.

More

ID – ODS now supports AUC based Vancomycin dosing!

ID – ODS now supports AUC based Vancomycin dosing!

ID – ODS, our state of the art system for Bayesian analysis and Monte Carlo Simulation, is now featuring AUC/MIC ratio based dose optimization for Vancomycin and the Aminoglycosides!

More

Manuscripts and Letters

2012 – Farkas A, Successful target attainment of telavancin at elevated MICs: fact or fiction?  2012, Antimicrobial Agents and Chemotherapy, 56: 4560

More

IDSA

2014 – Barry P.; Deck D.; Farkas A.; Pharmacokinetic modeling of linezolid dosing regimens for multidrug resistant tuberculosis

2013 – Farkas A, Rowin K; Pharmacodynamics of doripenem in critically ill patients: does race matter

More